IE
WST icon

Israel Englander’s West Pharmaceutical WST Stock Holding History

Israel Englander’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$525K – 6523
2025
Q3 		$525K Sell
2,000
-2,000
-50% -$486K ﹤0.01% 5035
2025
Q2 		$875K Sell
4,000
-4,400
-52% -$941K ﹤0.01% 4509
2025
Q1 		$1.88M Sell
8,400
-2,700
-24% -$744K ﹤0.01% 3838
2024
Q4 		$3.64M Buy
11,100
+5,000
+82% +$1.57M ﹤0.01% 3124
2024
Q3 		$1.83M Sell
6,100
-54,900
-90% -$16.8M ﹤0.01% 3777
2024
Q2 		$20.1M Buy
61,000
+55,900
+1,096% +$19.8M 0.01% 1497
2024
Q1 		$2.02M Sell
5,100
-9,900
-66% -$3.66M ﹤0.01% 3732
2023
Q4 		$5.28M Buy
+15,000
New +$5.31M ﹤0.01% 2743
2022
Q4 		– Sell
-5,000
Closed -$1.23M – 7116
2022
Q3 		$1.23M Sell
5,000
-55,000
-92% -$16.8M ﹤0.01% 4157
2022
Q2 		$18.1M Buy
60,000
+10,000
+20% +$3.25M 0.01% 1414
2022
Q1 		$20.5M Buy
50,000
+19,000
+61% +$7.44M 0.01% 1368
2021
Q4 		$14.5M Buy
31,000
+16,000
+107% +$6.89M 0.01% 1748
2021
Q3 		$6.37M Buy
+15,000
New +$6.32M ﹤0.01% 2590
2019
Q2 		– Sell
-4,000
Closed -$441K – 4518
2019
Q1 		$441K Buy
+4,000
New +$416K ﹤0.01% 3350

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Israel Englander's WST Position: Q2 2026 in Review

Israel Englander increased its West Pharmaceutical (WST) stake by 55% in Q2 2026, buying an estimated $2.3M and bringing the position to 21,290 shares worth $7.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Israel Englander first reported a position in WST in Q4 2013 and has held it in 46 quarters since. The position peaked at $204M in Q1 2024. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Israel Englander held 21,290 shares of West Pharmaceutical worth $7.64M as of Q2 2026.
  • Israel Englander bought 7,515 West Pharmaceutical shares in Q2 2026, an estimated $2.3M.
  • West Pharmaceutical made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2577 holding.
  • Israel Englander first reported a position in West Pharmaceutical in Q4 2013 and has held it in 46 quarters since.
  • Israel Englander's West Pharmaceutical position peaked at $204M in Q1 2024.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.